Purificación
Martínez del Prado
Hospital Universitario de Basurto
Bilbao, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario de Basurto (21)
2024
2023
-
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry
Breast Cancer Research and Treatment, Vol. 201, Núm. 2, pp. 151-159
2022
-
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial
Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661
-
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis
European Journal of Internal Medicine, Vol. 105, pp. 30-37
2021
-
Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer
Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 2, pp. 135.e17-135.e23
2019
-
Biological and prognostic differences between symptomatic colorectal carcinomas and those detected by screening
European Journal of Surgical Oncology, Vol. 45, Núm. 10, pp. 1876-1881
-
Impact of an osteoporosis specialized unit on bone health in breast cancer survivals treated with aromatase inhibitors
Reumatologia Clinica, Vol. 15, Núm. 4, pp. 211-217
2018
-
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
Oncologist, Vol. 23, Núm. 4, pp. 422-432
-
Outcomes of open versus laparoscopic surgery in patients with colon cancer
European Journal of Surgical Oncology, Vol. 44, Núm. 9, pp. 1344-1353
2017
-
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study
PLoS ONE, Vol. 12, Núm. 10
-
Functional proteomics outlines the complexity of breast cancer molecular subtypes
Scientific Reports, Vol. 7, Núm. 1
2016
-
Albumin-Bound (NAB) Paclitaxel, Abraxane®
The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 7-17
-
Docetaxel.Taxotere®
The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 139-145
-
Gemcitabine. Gemzar®
The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 197-205
2015
-
Introduction. Venous thromboembolism in patients with cancer
Medicina Clinica
2013
-
Chemoradiation of rectal cancer
Minerva Chirurgica, Vol. 68, Núm. 1, pp. 11-26
-
Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. the large experience of the spanish national tumor registry (RGETNE)
Neuroendocrinology, Vol. 98, Núm. 2, pp. 156-168
2011
-
Risk-adapted treatment in clinical stage I testicular seminoma: The third Spanish Germ Cell Cancer Group study
Journal of Clinical Oncology, Vol. 29, Núm. 35, pp. 4677-4681
2010
-
Adjuvant docetaxel for high-risk, node-negative breast cancer
New England Journal of Medicine, Vol. 363, Núm. 23, pp. 2200-2210
-
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)
Annals of Oncology, Vol. 21, Núm. 9, pp. 1794-1803